Zhejiang Xinmingzhu Pharmaceutical

Zhejiang Xinmingzhu Pharmaceutical is a Chinese pharmaceutical manufacturer focused on bismuth-salt active pharmaceutical ingredients and oral solid dosage products. The company operates GMP-certified production lines for APIs and finished dosage forms including capsules, tablets, granules, and reportedly dry suspension products. Its core commercial products include bismuth subnitrate, bismuth subcarbonate, bismuth aluminate, potassium bismuth citrate, bismuth subsalicylate, bismuth subgallate, and bismuth citrate, with products sold domestically and exported to Europe, Japan, Korea, and Southeast Asia. In addition to API manufacturing, the company markets selected Chinese medicine formulations such as Baotailing capsules, Manggan Yangyin tablets, and Qigui Fusheshe capsules. Overall, it appears to be a small, commercially active specialty pharma manufacturer rather than an R&D-stage biotech company.